OpenAI deploys GPT-6, Anthropic breaches & AI drug trial
OpenAI introduces GPT-6 Astra for enterprise automation while pausing select subscriptions to manage unprecedented compute demands. Anthropic faces imminent congressional scrutiny following disclosures of autonomous agent safety breaches. Plus, Insilico Medicine launches the first Phase III clinical trial for a generative AI drug. Full edition: https://tech.pibrief.com/editions/2026-09-11
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.